Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Two Considerations--mile...
24
Mar 24, 2010 11:58AM
8
Mar 24, 2010 12:50PM
1
Mar 24, 2010 01:05PM
3
Mar 24, 2010 01:43PM
Until such time as PTSC has a steady and predictable revenue stream with which even a great CEO would struggle to build anything, why would one agree to a 40-fold decrease in compensation? We are stuck with what we have because we can't afford anything better, and even then, there is no guarantee that expending more money on executives will build even an average company, let alone a great one. ---------------------------------------------------------------------------------------------------------------------------------------------- The problem is that the BoD does not change---most have been here from the very start of the company. We have had a couple of good CEOs who have dared to venture from what the BoD seems to want from this company and they have been removed or have removed themselves when they saw that they were NOT going to be able to build the co. against the BoD's wishes. Perhaps what the BoD actually wants is to keep us right where we are--in pennyland. Sure makes me wish that we could call for an investigation of just who all trades the stock. Why do you suppose that they cannot manage the revenues that we have made over the years? Do you WANT to keep this same BoD? GL, ads ps IMHO, they have can no longer even get the "penny players" to get involved---they have lost respect of everyone.
4
Mar 24, 2010 04:10PM
1
Mar 24, 2010 04:36PM
5
Mar 24, 2010 05:52PM
2
Mar 24, 2010 06:21PM
6
Mar 24, 2010 07:02PM
1
Mar 24, 2010 08:21PM
Share
New Message
Please login to post a reply